MigraineMind research summary
Serum Concentration Relationships of Candesartan in Migraine Prevention.
Basic Clin Pharmacol Toxicol | 2026
Observational studySummary
Candesartan is a medication used to prevent migraines. This research studied how different doses of candesartan affect migraine prevention. The study involved 166 adults, mostly women, with episodic or chronic migraines. Participants took candesartan and recorded their headaches daily for 16 weeks. Blood samples were taken to measure drug levels. The doses varied between 4 mg and 8 mg, and both doses were well tolerated. No significant differences in side effects were found between the two doses. However, researchers noticed that individuals had different levels of the drug in their blood. Higher levels of candesartan were linked to fewer migraine attacks. This suggests that optimizing the dose might improve treatment outcomes for migraine sufferers. Understanding how the drug works in different people can help doctors provide better care for those with migraines. Clinical relevance: This study highlights the importance of personalized dosing of candesartan for effective migraine prevention.
Related migraine research topics
Original research
Read the original publication and review its full methods and findings on PubMed.
MigraineMind is an educational resource designed to complement—not replace—the original scientific literature or clinical judgement. This page is an AI-generated summary of the available paper information and may contain errors. Please consult the original publication.
